查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1855865

2025年全球疾病登錄軟體市場報告

Disease Registry Software Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，疾病登記軟體市場發展迅速，預計從2024年的13.9億美元成長到2025年的15.5億美元，複合年成長率達11.6%。預測期內的成長與慢性病負擔加重、臨床研究和試驗的擴展、罕見患者病率上升、電子健康記錄（EHR）的快速普及以及慢性病流行趨勢的加劇密切相關。

預計未來幾年疾病登記軟體市場將快速成長，到2029年市場規模將達到23.8億美元，年複合成長率（CAGR）為11.2%。預測期內的成長與以下因素密切相關：基於價值的醫療模式的日益普及、真實世界證據（RWE）的廣泛應用、舉措醫療計劃的推進、慢性病和文明病患病率的上升，以及對以患者為中心的醫療保健的日益重視。預測期內的關鍵趨勢包括：醫療保健IT基礎設施的進步、與遠端醫療和遠端監測的整合、與物聯網（IoT）設備和穿戴式裝置的連接、資料視覺化和儀表板的增強，以及區塊鏈在資料安全和互通性的應用。

個人化醫療的日益普及預計將推動疾病登記軟體市場的擴張。個人化醫療是一種根據個人的基因組成、生活方式和環境來客製化治療和預防措施的方法。這項轉變主要得益於基因組學的進步，基因組學能夠準確地識別基因變異並開發客製化治療方案。疾病登記軟體在個人化醫療中發揮關鍵作用，它系統地收集和管理患者健康數據。這些系統簡化了數據存取和分析，最終改善患者預後並推動精準醫療領域的發展。例如，根據個人化醫療聯盟的報告，美國食品藥物管理局)在 2023 年核准了26 種個人化新藥，較 2022 年顯著增加。因此，個人化醫療的日益普及正在推動對疾病登記軟體的需求。

疾病登記軟體市場的主要企業正致力於建立以患者為中心的登記系統，包括旨在追蹤治療結果並支援個人化醫療的數位化系統。數位化登記系統是系統性地收集、儲存和管理病患健康資訊的電子平台，取代了傳統的紙本方式。例如，2025年8月，美國心臟病學會啟動了CONNECT-HCM登記系統，這是一個旨在提高對肥厚型心肌病（HCM，最常見的遺傳性心血管疾病）的認知和管理的全國性數位化登記系統。該登記系統支援跨多個醫療機構的患者直接註冊，從而彌補了診斷和治療方面的不足。該登記系統透過Hugo Connect平台將登記資料與電子健康記錄連接起來，使研究人員能夠追蹤患者的症狀、影像學結果、治療方案和治療結果隨時間的變化。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球疾病登記軟體：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球疾病登錄軟體市場：成長率分析
  • 全球疾病登錄軟體市場表現：規模與成長，2019-2024年
  • 全球疾病登記軟體市場預測：規模與成長，2024-2029年，2034年預測
  • 全球疾病登錄軟體：潛在市場規模 (TAM)

第6章 市場細分

  • 全球疾病登記軟體市場按類型分類，實際數據及預測數據（2019-2024年、2024-2029年預測、2034年預測）
  • 獨立版
  • 一體化
  • 全球疾病登記軟體市場（依資料庫）、實際資料及預測（2019-2024年、2024-2029年預測、2034年預測）
  • 公共
  • 商業的
  • 全球疾病登記軟體市場依部署模式分類，實際數據及預測（2019-2024年、2024-2029年預測、2034年預測）。
  • 本地部署
  • 雲端基礎的
  • 全球疾病登錄軟體市場：依最終用戶分類，實際數據和預測數據，2019-2024年、2024-2029年預測數據、2034年預測數據
  • 醫院
  • 政府機構
  • 研究中心
  • 製藥公司
  • 其他最終用戶
  • 全球疾病登記軟體市場：依獨立模式、類型、實際值及預測值分類的細分市場，2019-2024年、2024-2029年預測值、2034年預測值
  • 病人登記軟體
  • 人口健康登記軟體
  • 研究註冊軟體
  • 客製化/單一疾病登記軟體
  • 全球疾病登錄軟體市場：依整合類型細分，實際資料及預測資料（2019-2024年、2024-2029年預測、2034年預測）。
  • 電子健康記錄(EHR) 整合註冊軟體
  • 診所管理系統 - 整合註冊軟體
  • 臨床決策支援（CDS）- 整合註冊軟體
  • 交換醫療資訊（HIE）- 整合註冊軟體

第7章 區域和國家分析

  • 全球疾病登錄軟體市場：依地區分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 全球疾病登記軟體市場：按國家/地區分類，實際值和預測值，2019-2024 年、2024-2029 年預測值、2034 年預測值

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 疾病登記軟體市場：競爭格局
  • 疾病登記軟體市場：公司概況
    • Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
    • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Epic Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Premier Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • MRO Corp.
  • ImageTrend Inc.
  • Anju Software Inc.
  • BayaTree Inc.
  • Medrio Inc.
  • ArborMetrix Inc.
  • Cedaron Medical Inc.
  • Evado Pty. Ltd.
  • OpenClinica LLC
  • Dacima Software Inc.
  • Global Vision Technologies Inc.
  • Ordinal Data Inc.
  • Healthmonix LLC
  • Axis Clinical Software Inc.
  • Vanderbilt University

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年疾病登錄軟體市場：提供新機會的國家
  • 2029年疾病登記軟體市場：提供新機會的細分市場
  • 2029年疾病登錄軟體市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38514

Disease registry software is a dedicated digital platform designed to gather, organize, and manage patient information related to specific diseases or medical conditions. It enables healthcare providers, researchers, and policymakers to track disease trends, evaluate treatment outcomes, maintain regulatory compliance, and support clinical decisions to enhance patient care and overall population health.

The primary categories of disease registry software are standalone and integrated. Standalone systems operate independently to collect, manage, and analyze disease-specific patient data without relying on hospital or clinic infrastructure. These databases can be public or commercial, with deployment options including on-premises and cloud-based models, and they serve hospitals, government agencies, research institutions, pharmaceutical companies, and other users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The disease registry software market research report is one of a series of new reports from The Business Research Company that provides disease registry software market statistics, including the disease registry software industry global market size, regional shares, competitors with the disease registry software market share, detailed disease registry software market segments, market trends, and opportunities, and any further data you may need to thrive in the disease registry software industry. This disease registry software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The disease registry software market size has grown rapidly in recent years. It will grow from $1.39 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be linked to the increasing burden of chronic diseases, expansion of clinical research and trials, rising prevalence of rare diseases, rapid adoption of electronic health records (EHRs), and the widespread occurrence of chronic conditions.

The disease registry software market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be linked to the expanding adoption of value-based care models, increased use of real-world evidence (RWE), growth of precision medicine initiatives, rising incidence of chronic and lifestyle-related diseases, and stronger emphasis on patient-centered healthcare. Key trends during the forecast period include advancements in healthcare IT infrastructure, integration with telehealth and remote monitoring, connection with internet of things (IoT) devices and wearables, enhanced data visualization and dashboards, and use of blockchain for data security and interoperability.

The growing adoption of personalized medicine is expected to drive the expansion of the disease registry software market. Personalized medicine is an approach that customizes treatment and prevention based on an individual's genetic makeup, lifestyle, and environment. This shift is largely driven by advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments. Disease registry software plays a crucial role in personalized medicine by systematically gathering and managing patient health data, enabling the creation of personalized treatment plans and supporting improved clinical decision-making. These systems streamline access to and analysis of data, ultimately enhancing patient outcomes and advancing the field of precision healthcare. For instance, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a substantial increase from 2022. As a result, the growing adoption of personalized medicine is fueling the demand for disease registry software.

Leading companies in the disease registry software market are focusing on creating patient-centric registries, such as digital systems designed to track outcomes and support personalized care. Digital registries are electronic platforms that systematically collect, store, and manage patient health information, replacing traditional paper-based methods. For example, in August 2025, the American College of Cardiology launched the CONNECT-HCM Registry, a nationwide digital registry aimed at improving the understanding and management of hypertrophic cardiomyopathy (HCM), the most common genetic cardiovascular condition. This registry allows for direct patient enrollment across multiple centers, addressing gaps in diagnosis and care. It links registry data with electronic health records via Arboretum's Hugo Connect platform, enabling researchers to track symptoms, imaging results, treatments, and outcomes over time.

In November 2023, Health Catalyst Inc., a U.S.-based healthcare analytics company, acquired Electronic Registry Systems Inc. (ERS) to enhance its oncology registry capabilities. With this acquisition, Health Catalyst integrates ERS's cancer data management expertise into its suite of tech-enabled managed services, improving data abstraction, reporting, and analytics for healthcare organizations. ERS is a U.S.-based company specializing in cancer registry software and services.

Major players in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., and Vanderbilt University.

North America was the largest region in the disease registry software market in 2024. The regions covered in disease registry software report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the disease registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The disease registry software market includes revenues earned by entities through patient data management, real-time data collection, integration with electronic health records, analytics and reporting, clinical research support, chronic disease management, and public health surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Disease Registry Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on disease registry software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for disease registry software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The disease registry software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Standalone; Integrated
  • 2) By Database: Public; Commercial
  • 3) By Deployment Mode: On-Premises; Cloud-Based
  • 4) By End-User: Hospitals; Government Organizations; Research Centers; Pharmaceutical Companies; Other End Users
  • Subsegments:
  • 1) By Standalone: Patient Registry Software; Population Health Registry Software; Research Registry Software; Custom Or Single-Disease Registry Software
  • 2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software; Practice Management System-Integrated Registry Software; Clinical Decision Support (CDS)-Integrated Registry Software; Health Information Exchange (HIE)-Integrated Registry Software
  • Companies Mentioned: Optum Inc.; IQVIA Holdings Inc.; Syneos Health Inc.; Epic Systems Corporation; Premier Inc.; MRO Corp.; ImageTrend Inc.; Anju Software Inc.; BayaTree Inc.; Medrio Inc.; ArborMetrix Inc.; Cedaron Medical Inc.; Evado Pty. Ltd.; OpenClinica LLC; Dacima Software Inc.; Global Vision Technologies Inc.; Ordinal Data Inc.; Healthmonix LLC; Axis Clinical Software Inc.; Vanderbilt University
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Disease Registry Software Market Characteristics

3. Disease Registry Software Market Trends And Strategies

4. Disease Registry Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Disease Registry Software Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Disease Registry Software PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Disease Registry Software Market Growth Rate Analysis
  • 5.4. Global Disease Registry Software Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Disease Registry Software Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Disease Registry Software Total Addressable Market (TAM)

6. Disease Registry Software Market Segmentation

  • 6.1. Global Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standalone
  • Integrated
  • 6.2. Global Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Public
  • Commercial
  • 6.3. Global Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.4. Global Disease Registry Software Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Government Organizations
  • Research Centers
  • Pharmaceutical Companies
  • Other End Users
  • 6.5. Global Disease Registry Software Market, Sub-Segmentation Of Standalone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Registry Software
  • Population Health Registry Software
  • Research Registry Software
  • Custom/Single-Disease Registry Software
  • 6.6. Global Disease Registry Software Market, Sub-Segmentation Of Integrated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Health Record (EHR)-Integrated Registry Software
  • Practice Management System-Integrated Registry Software
  • Clinical Decision Support (CDS)-Integrated Registry Software
  • Health Information Exchange (HIE)-Integrated Registry Software

7. Disease Registry Software Market Regional And Country Analysis

  • 7.1. Global Disease Registry Software Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Disease Registry Software Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Disease Registry Software Market

  • 8.1. Asia-Pacific Disease Registry Software Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Disease Registry Software Market

  • 9.1. China Disease Registry Software Market Overview
  • 9.2. China Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Disease Registry Software Market

  • 10.1. India Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Disease Registry Software Market

  • 11.1. Japan Disease Registry Software Market Overview
  • 11.2. Japan Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Disease Registry Software Market

  • 12.1. Australia Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Disease Registry Software Market

  • 13.1. Indonesia Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Disease Registry Software Market

  • 14.1. South Korea Disease Registry Software Market Overview
  • 14.2. South Korea Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Disease Registry Software Market

  • 15.1. Western Europe Disease Registry Software Market Overview
  • 15.2. Western Europe Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Disease Registry Software Market

  • 16.1. UK Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Disease Registry Software Market

  • 17.1. Germany Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Disease Registry Software Market

  • 18.1. France Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Disease Registry Software Market

  • 19.1. Italy Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Disease Registry Software Market

  • 20.1. Spain Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Disease Registry Software Market

  • 21.1. Eastern Europe Disease Registry Software Market Overview
  • 21.2. Eastern Europe Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Disease Registry Software Market

  • 22.1. Russia Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Disease Registry Software Market

  • 23.1. North America Disease Registry Software Market Overview
  • 23.2. North America Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Disease Registry Software Market

  • 24.1. USA Disease Registry Software Market Overview
  • 24.2. USA Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Disease Registry Software Market

  • 25.1. Canada Disease Registry Software Market Overview
  • 25.2. Canada Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Disease Registry Software Market

  • 26.1. South America Disease Registry Software Market Overview
  • 26.2. South America Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Disease Registry Software Market

  • 27.1. Brazil Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Disease Registry Software Market

  • 28.1. Middle East Disease Registry Software Market Overview
  • 28.2. Middle East Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Disease Registry Software Market

  • 29.1. Africa Disease Registry Software Market Overview
  • 29.2. Africa Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Disease Registry Software Market Competitive Landscape And Company Profiles

  • 30.1. Disease Registry Software Market Competitive Landscape
  • 30.2. Disease Registry Software Market Company Profiles
    • 30.2.1. Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Epic Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Premier Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Disease Registry Software Market Other Major And Innovative Companies

  • 31.1. MRO Corp.
  • 31.2. ImageTrend Inc.
  • 31.3. Anju Software Inc.
  • 31.4. BayaTree Inc.
  • 31.5. Medrio Inc.
  • 31.6. ArborMetrix Inc.
  • 31.7. Cedaron Medical Inc.
  • 31.8. Evado Pty. Ltd.
  • 31.9. OpenClinica LLC
  • 31.10. Dacima Software Inc.
  • 31.11. Global Vision Technologies Inc.
  • 31.12. Ordinal Data Inc.
  • 31.13. Healthmonix LLC
  • 31.14. Axis Clinical Software Inc.
  • 31.15. Vanderbilt University

32. Global Disease Registry Software Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Disease Registry Software Market

34. Recent Developments In The Disease Registry Software Market

35. Disease Registry Software Market High Potential Countries, Segments and Strategies

  • 35.1 Disease Registry Software Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Disease Registry Software Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Disease Registry Software Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer